Targeting ZMIZ1 induces differentiation in acute myeloid leukemia via chromatin remodeling
{{output}}
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy characterized by profound transcriptional dysregulation and impaired hematopoietic differentiation. While differentiation therapy has revolutionized treatment in acute promyelocytic leukemia ... ...